When Faced with a Lawsuit, Insurance May Ease Your Pain

Policyholder Advisor & Alert

PUBLISHED ON: September 1, 2002

Download PDF

On July 9, 2002, a major clinical trial of the risks and benefits of hormone replacement therapy (“HRT”) for menopausal women was cut short. The trial, which involved 16,660 women, was halted because the data revealed that women undergoing HRT using the drug Prempro, a combination pill of estrogen and progestin, allegedly had a higher risk of breast cancer, coronary heart disease, stroke and pulmonary embolisms.

Related People

Insurance Recovery Attorney | Anderson Kill LLP
Rhonda D. Orin
Managing Shareholder (Branch)
Washington, DC
Partner | Anderson Kill LLP
Michele A. Gallagher
Washington, DC

Related Practice Areas

Related Publications